ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

NAUT Nautilus Biotechnology Inc

2.80
0.11 (4.09%)
Última actualización: 09:58:28
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Nautilus Biotechnology Inc NAUT NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.11 4.09% 2.80 09:58:28
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.71 2.71 2.815 2.69
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
30/4/202407:00GLOBENautilus Biotechnology Reports First Quarter 2024 Financial..
11/4/202407:00GLOBENautilus Biotechnology to Announce First Quarter 2024..
06/3/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
06/3/202415:39EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05/3/202415:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202407:00GLOBENautilus Biotechnology Reports Fourth Quarter and Fiscal..
28/2/202406:26EDGAR2Form 8-K - Current report
28/2/202406:25EDGAR2Form S-3 - Registration statement under Securities Act of..
28/2/202406:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
28/2/202406:04EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/2/202406:03EDGAR2Form 8-K - Current report
22/2/202407:00GLOBENautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ..
07/2/202407:00GLOBENautilus Biotechnology to Announce Fourth Quarter and Full..
14/12/202315:17EDGAR2Form 8-K - Current report
30/11/202307:00GLOBENautilus Biotechnology Co-founder and Chief Scientist Parag..
01/11/202307:05GLOBENautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice..
31/10/202315:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202307:05GLOBENautilus Biotechnology Reports Third Quarter 2023 Financial..
11/10/202307:05GLOBENautilus Biotechnology to Announce Third Quarter Financial..
06/9/202306:30GLOBENautilus Biotechnology to Participate in Upcoming September..
04/8/202307:00GLOBENautilus Biotechnology to Participate in Upcoming August..
02/8/202315:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/8/202306:30GLOBENautilus Biotechnology Reports Second Quarter 2023 Financial..
11/7/202308:23GLOBENautilus Biotechnology to Announce Second Quarter Financial..
24/5/202307:05GLOBENautilus Biotechnology to Participate in Upcoming June..

Su Consulta Reciente

Delayed Upgrade Clock